VoxNeuro
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Kendall Sq Fl 14, Cambridge, ...Phone Number
(857) 214-7965Website
www.voxneuro.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About VoxNeuro
VoxNeuro is a cognitive health assessment that uses established neuropsychological and cognitive tests in combination with EEG-based brain performance software to objectively score cognitive function.Explore more
VoxNeuro Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VoxNeuro your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if VoxNeuro has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at VoxNeuro
Click to see if VoxNeuro had a recent Job posting/layoffs
Funding: Get notified immidiatlly once VoxNeuro has new funding data
Product Launch: Get notified when VoxNeuro launches new products
Check out if VoxNeuro is spiking on competitors!
VoxNeuro, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on VoxNeuro recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined VoxNeuro as Masked Content
Find more new buyers
Compare Similar Companies to VoxNeuro
Compare insights from companies similar to VoxNeuro, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VoxNeuro is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VoxNeuro is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VoxNeuro.
VoxNeuro financials insights
Gather financial insights about VoxNeuro, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$3.4M
VoxNeuro Tech Stack
A closer look at the technologies used by VoxNeuro
Most Recent Scoops
Funding
New Hire
Executive Move
Lateral Move
Executive Move
Open Position
New Hire
Executive Move
New Hire
VoxNeuro News & Media
VoxNeuro secures $4 million CAD to help diagnose concussions and Alzheimer’s disease
Backed by decades of research, VoxNeuro aims to bring objectivity to brain health assessments. The post VoxNeuro secures $4 million CAD to help diagnose concussions and Alzheimer’s disease first appeared on BetaKit.VoxNeuro Announces Collaboration with the Canadian Armed Forces and Launch of Clinical Study Measuring Impact of Training-Related Sub-Concussive Exposure
TORONTO--(BUSINESS WIRE)--VoxNeuro Inc. (“VoxNeuro” or the “Company”), a commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, has announced a new partnership with the Canadian Armed Forces (“CAF”). VoxNeuro and CAF have partnered to study the cognitive effects following intense military training regimens designed to reflect a combat environment and blast exposure. Despite the high prevalence of cognitive issues inVoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease
BOSTON--(BUSINESS WIRE)--VoxNeuro Inc. (“VoxNeuro” or the “Company”), a commercial stage Software-as-a-Medical-Device (SaMD) brain health company that analyzes brain biomarkers to assess cognitive function, announced a new partnership with Boston University (“BU”), a world-class institution and private research university at the forefront of neuroscience and neurotechnology. In partnership with BU, VoxNeuro has launched two studies that will evaluate its cognitive health assessment platform inVoxNeuro Announces Significant Milestones as it Embarks on its Mission to Become “The Brain Company”
TORONTO--(BUSINESS WIRE)-- #ABI--VoxNeuro Inc. (“VoxNeuro” or the “Company”), a Software as a Medical Device (SaMD) brain health company that analyzes brain-based biomarkers to assess cognitive function, announced a number of significant developments including (i) receipt of US patent 11278230 entitled “Systems and methods for cognitive health assessment” which provides protection for VoxNeuro’s competitive advantage (specific EEG-based neuropsychological assessments that generate event-related
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VoxNeuro
Sign Up For FreeTo access detailed company insights
VoxNeuro is a cognitive health assessment that uses established neuropsychological and cognitive tests in combination with EEG-based brain performance software to objectively score cognitive function.... Read More
